XPeng Q4 2025 Earnings EPS Surges to Profitability Stock Jumps 6 FSEA Q3 2024 Earnings Modest Profit Amid Narrowing Margins OCUL Q1 2026 Earnings EPS Misses Estimates as PreCommercial Biotech Continues Development RVSN Q3 2023 Earnings EPS Exceeds Estimates Despite Absence of Revenue LZM Q2 2024 Earnings EPS Misses Estimates Shares Rise 876 CREG Q1 2026 Earnings Reported Loss Per Share of 003 Stock Declines 125 Amid Missing Revenue Data